GleamWall
中文EN

GTHP GUIDED THERAPEUTICS INC

Electromedical & Electrotherapeutic Apparatus · OTC · SEC CIK 924515 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY283.1%
TTM net income YoY-15.6%
TTM EPS YoY40.0%
Revenue 3-yr CAGR117.8%
Net income 3-yr CAGR—

Margins

Gross margin80.4%
Operating margin-304.0%
Net margin-446.2%
FCF margin—
EBITDA margin-302.5%

Returns

ROE—
ROA-267.0%
ROIC (approx.)—
Asset turnover0.60x

Leverage & solvency

Liabilities / assets546.1%
Debt / equity—
Current ratio0.11x
Interest coverage-3.31x

Cash quality & payout

Operating cash flow / net income0.52x
Accruals ratio-128.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$92,000$0$0$590,000$60,000$117,000$0$1,000
Cost of revenue$2,000$0$0$132,000$25,000$38,000$0$3,000
Gross profit$90,000$0$0$458,000$35,000$79,000$0-$2,000
R&D expense$204,000$34,000$45,000$127,000$136,000$133,000$74,000$140,000
SG&A expense$384,000$423,000$451,000$1.02M$362,000$658,000$267,000$323,000
Operating income-$583,000-$478,000-$302,000-$710,000-$485,000-$763,000-$414,000-$534,000
Interest expense$156,000$136,000$151,000$184,000$129,000$157,000$147,000$134,000
Pretax income-$720,000-$605,000-$500,000-$1.22M-$742,000-$811,000-$427,000-$652,000
Income tax$0$0$0$0$0$0$0$0
Net income-$720,000-$605,000-$500,000-$1.22M-$742,000-$811,000-$427,000-$652,000
EBITDA-$580,000-$476,000-$300,000-$707,000-$483,000-$760,000-$412,000-$532,000
EPS (basic)-0.01-0.01-0.01—-0.01-0.01-0.01—
EPS (diluted)-0.01-0.01-0.01—-0.01-0.01-0.01—
Weighted avg. shares (diluted)96.54M96.54M88.84M—81.69M78.84M68.29M—
Balance sheet
Cash & equivalents$111,000$12,000$369,000$63,000$87,000$185,000$115,000$388,000
Receivables$3,000$4,000$4,000$4,000$6,000$8,000$2,000$3,000
Inventory$511,000$500,000$469,000$448,000$583,000$595,000$633,000$633,000
Current assets$734,000$527,000$911,000$605,000$799,000$811,000$811,000$1.20M
PP&E, net$9,000$11,000$13,000$16,000$18,000$18,000$21,000$23,000
Total assets$1.38M$1.20M$1.60M$1.32M$903,000$940,000$967,000$1.38M
Current liabilities$6.93M$6.17M$5.96M$6.64M$6.47M$6.38M$5.90M$6.16M
Long-term debt$140,000$53,000$91,000—————
Total debt$140,000$53,000$91,000—————
Total liabilities$7.51M$6.96M$6.78M$7.33M$6.55M$6.41M$6.00M$6.27M
Shareholders' equity-$6.14M-$5.76M-$5.18M-$6.01M-$5.65M-$5.47M-$5.03M-$4.89M
Net debt$29,000$41,000-$278,000—————
Shares outstanding98,18896.54M96.51M86,15483.60M78.97M77.97M65.13M
Cash flow statement
Operating cash flow-$349,000-$319,000-$617,000-$291,000-$277,000-$169,000-$331,000-$332,000
Capital expenditure———$0———$0
Free cash flow———-$291,000———-$332,000
Investing cash flow———$0———$0
Financing cash flow$448,000-$38,000$923,000$267,000$181,000$239,000$58,000$526,000
Depreciation & amortization$3,000$2,000$2,000$3,000$2,000$3,000$2,000$2,000
Stock-based compensation$22,000$11,000$68,000$25,000$22,000$329,981$19,000-$13,000

Free plan shows the latest 8 periods; Pro shows all 64 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.